These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 12644894)
21. Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel. Fuhrer DK; Kobayashi M; Jiang H Diabetes Obes Metab; 2001 Dec; 3(6):393-402. PubMed ID: 11903410 [TBL] [Abstract][Full Text] [Related]
22. Inhibitory role for calcineurin in stimulus-secretion coupling revealed by FK506 and cyclosporin A in pituitary corticotrope tumor cells. Antoni FA; Shipston MJ; Smith SM Biochem Biophys Res Commun; 1993 Jul; 194(1):226-33. PubMed ID: 7687429 [TBL] [Abstract][Full Text] [Related]
23. [Calcineurin inhibitors and mechanisms that are responsible for the appearance of post-transplant diabetes mellitus]. Ippoliti GB; Viganò M G Ital Nefrol; 2003; 20 Suppl 25():S11-4. PubMed ID: 14523907 [TBL] [Abstract][Full Text] [Related]
24. A calcium-initiated signaling pathway propagated through calcineurin and cAMP response element-binding protein activates proenkephalin gene transcription after depolarization. Hahm SH; Chen Y; Vinson C; Eiden LE Mol Pharmacol; 2003 Dec; 64(6):1503-11. PubMed ID: 14645681 [TBL] [Abstract][Full Text] [Related]
25. Calcineurin inhibitors, cyclosporin A and tacrolimus inhibit expression of inducible nitric oxide synthase in colon epithelial and macrophage cell lines. Hämäläinen M; Lahti A; Moilanen E Eur J Pharmacol; 2002 Jul; 448(2-3):239-44. PubMed ID: 12144947 [TBL] [Abstract][Full Text] [Related]
26. Calcineurin is an important factor involved in glucose uptake in human adipocytes. Fonseca ACRG; Carvalho E; Eriksson JW; Pereira MJ Mol Cell Biochem; 2018 Aug; 445(1-2):157-168. PubMed ID: 29380240 [TBL] [Abstract][Full Text] [Related]
27. Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology. Reynolds NJ; Al-Daraji WI Clin Exp Dermatol; 2002 Oct; 27(7):555-61. PubMed ID: 12464150 [TBL] [Abstract][Full Text] [Related]
28. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells. Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331 [TBL] [Abstract][Full Text] [Related]
29. Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus. Jørgensen KA; Koefoed-Nielsen PB; Karamperis N Scand J Immunol; 2003 Feb; 57(2):93-8. PubMed ID: 12588654 [TBL] [Abstract][Full Text] [Related]
30. Rapamycin, FK506 and cyclosporin A inhibit human prolactin gene expression. Wera S; Belayew A; Martial JA FEBS Lett; 1995 Jan; 358(2):158-60. PubMed ID: 7530217 [TBL] [Abstract][Full Text] [Related]
31. The calcineurin activity profiles of cyclosporin and tacrolimus are different in stable renal transplant patients. Koefoed-Nielsen PB; Karamperis N; Højskov C; Poulsen JH; Jørgensen KA Transpl Int; 2006 Oct; 19(10):821-7. PubMed ID: 16961774 [TBL] [Abstract][Full Text] [Related]
32. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. Redmon JB; Olson LK; Armstrong MB; Greene MJ; Robertson RP J Clin Invest; 1996 Dec; 98(12):2786-93. PubMed ID: 8981925 [TBL] [Abstract][Full Text] [Related]
33. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1. Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327 [TBL] [Abstract][Full Text] [Related]
34. Proteasomal degradation of IRS-2, but not IRS-1 by calcineurin inhibition: attenuation of insulin-like growth factor-I-induced GSK-3beta and ERK pathways in adrenal chromaffin cells. Satoh S; Yanagita T; Maruta T; Nemoto T; Yoshikawa N; Kobayashi H; Tono T; Wada A Neuropharmacology; 2008 Jul; 55(1):71-9. PubMed ID: 18538359 [TBL] [Abstract][Full Text] [Related]
35. Effects of mTOR and calcineurin inhibitors combined therapy in Epstein-Barr virus positive and negative Burkitt lymphoma cells. Wowro SJ; Schmitt KRL; Tong G; Berger F; Schubert S Int Immunopharmacol; 2016 Jan; 30():9-17. PubMed ID: 26613512 [TBL] [Abstract][Full Text] [Related]
36. Up-regulation of cell surface sodium channels by cyclosporin A, FK506, and rapamycin in adrenal chromaffin cells. Shiraishi S; Yanagita T; Kobayashi H; Uezono Y; Yokoo H; Minami SI; Takasaki M; Wada A J Pharmacol Exp Ther; 2001 May; 297(2):657-65. PubMed ID: 11303055 [TBL] [Abstract][Full Text] [Related]
37. Calcium signaling pathway involving calcineurin regulates interleukin-8 gene expression through activation of NF-kappaB in human osteoblast-like cells. Mitsuyama H; Kambe F; Murakami R; Cao X; Ishiguro N; Seo H J Bone Miner Res; 2004 Apr; 19(4):671-9. PubMed ID: 15005855 [TBL] [Abstract][Full Text] [Related]
38. Calcineurin inhibitors down-regulate iNOS expression by destabilizing mRNA. Hämäläinen M; Korhonen R; Moilanen E Int Immunopharmacol; 2009 Feb; 9(2):159-67. PubMed ID: 18692599 [TBL] [Abstract][Full Text] [Related]
39. Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. Tomono M; Toyoshima K; Ito M; Amano H; Kiss Z Arch Biochem Biophys; 1998 May; 353(2):374-8. PubMed ID: 9606972 [TBL] [Abstract][Full Text] [Related]
40. Neuronal survival activity of s100betabeta is enhanced by calcineurin inhibitors and requires activation of NF-kappaB. Alexanian AR; Bamburg JR FASEB J; 1999 Sep; 13(12):1611-20. PubMed ID: 10463953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]